Search - tctmd.com

Displaying 81 - 100 of 879

Sort: Relevancy | Date

News Daily News

Orthopedic and Radiation Injuries Unchanged in Cath Lab Staff Since 2014

L.A. McKeown

March 05, 2025

News Daily News

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

L.A. McKeown

February 11, 2025

News Daily News

Intravascular Imaging During PCI Should Be a Performance Metric, Researchers Say

Todd Neale

February 11, 2025

News Conference News STS 2025

Surgery Outdoes Percutaneous Treatment for Patients With CAD, Aortic Stenosis

Yael L. Maxwell

February 05, 2025

News Daily News

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

Yael L. Maxwell

January 23, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Daily News

Some Guidance for Managing Patients With AS and CAD: Review

Yael L. Maxwell

December 24, 2024

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Conference News PCR London Valves 2024

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Michael O'Riordan

November 27, 2024

News Conference News PCR London Valves 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News AHA 2024

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

Todd Neale

November 18, 2024

News Conference News TCT 2024

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Yael L. Maxwell

November 07, 2024

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Caitlin E. Cox

October 30, 2024

News Conference News TCT 2024

Preprocedural AI-QCA Matches OCT-Guided PCI for Noncomplex Lesions

Yael L. Maxwell

October 30, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Advertisement

Orthopedic and Radiation Injuries Unchanged in Cath Lab Staff Since 2014

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

Intravascular Imaging During PCI Should Be a Performance Metric, Researchers Say

Surgery Outdoes Percutaneous Treatment for Patients With CAD, Aortic Stenosis

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

Top Coronary Artery Disease News in 2024

Some Guidance for Managing Patients With AS and CAD: Review

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Preprocedural AI-QCA Matches OCT-Guided PCI for Noncomplex Lesions

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content